A phase I, double-blind, randomized, placebo-controlled ascending IV [intravenous] single-dose tolerance and pharmacokinetic study of trosdesquemine [MSI 1436; Genaera Corporation] in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Trodusquemine (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacokinetics
- 08 Jan 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 25 Oct 2007 Status changed from recruiting to in progress.
- 08 Aug 2007 Interim results have been reported.